COMMUNIQUÉS West-GlobeNewswire

ViroGates releases third quarter 2018 results

24/10/2018 - 12:20

Company announcement no. 7-2018 Birkerød, 24 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for [...]

Mesoblast Expands Partnership With JCR Pharmaceuticals for Treatment of Wound Healing in Epidermolysis Bullosa

24/10/2018 - 12:05

NEW YORK and MELBOURNE, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for wound healing [...]

Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm

24/10/2018 - 12:01

Press Release 24 October 2018 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm Immunicum AB (publ; IMMU.ST) announced today that the Company will host two investor events in October. At both [...]

Orion and Amgen to collaborate on the commercialisation of AMGEVITA® (biosimilar adalimumab) in Finland

24/10/2018 - 11:31

Orion Corporation Press Release 24 October 2018 at 12.30 p.m. EEST Orion and Amgen to collaborate on the commercialisation of AMGEVITA ® (biosimilar adalimumab) in Finland Orion Corporation and Amgen have signed an [...]

Opthea To Present Update at the Ophthalmology Innovation Summit in Chicago

24/10/2018 - 11:30

MELBOURNE, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical-stage biopharmaceutical company developing novel biologic therapies to treat back-of-the-eye diseases, announced today that Dr [...]

Orion Group Interim Report January-September 2018

24/10/2018 - 11:01

ORION CORPORATION INTERIM REPORT JANUARY-SEPTEMBER 2018 24 OCTOBER 2018 at 12.00 EEST Orion Group Interim Report January-September 2018 Orion's net sales for continuing operations in January-September 2018 totalled EUR [...]

PCI Biotech: Capital increase registered and listing of new shares

24/10/2018 - 11:01

Oslo, Norway, 24 October 2018. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 170,000 new shares following exercise of employee [...]

EssilorLuxottica : Mise à disposition d'une note complémentaire au prospectus ayant reçu le visa n°18-460 de l'AMF le 28 septembre 2018

24/10/2018 - 08:01

Mise à disposition d'une note complémentaire au prospectus ayant reçu le visa n°18-460 de l'AMF le 28 septembre 2018 Version PDF du communiqué Charenton-le-Pont, France (24 octobre 2018 - 8h00) - EssilorLuxottica [...]

Rule 2.9 Announcement

24/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 October 2018 [...]

Interim report for the first nine months of 2018

24/10/2018 - 07:58

Read the full announcement in PDF Attachment 2018_60_Q32018_CompanyAnnouncement_EN_FINAL

Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer - The primary endpoint was met

24/10/2018 - 07:31

ORION CORPORATION STOCK EXCHANGE RELEASE 24 OCTOBER 2018 AT 8.30 a.m. EEST Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer - The [...]

Santhera Announces Start of Phase Ib/IIa Trial with POL6014 in Patients with Cystic Fibrosis

24/10/2018 - 07:01

Pratteln, Switzerland, October 24, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces the start of a Phase Ib/IIa multiple ascending dose (MAD) trial with POL6014 in patients with cystic fibrosis (CF). POL6014 is an [...]

ISS and Glass Lewis recommend ICC Shareholders vote FOR Arrangement with Aurora Cannabis

24/10/2018 - 03:58

VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC ) (TSX-V: ICC) is pleased to announce that Institutional Shareholder Services Inc. ( ISS ) and Glass Lewis & Co. ( [...]

Lexington Provides Q3 Corporate Review

24/10/2018 - 00:37

VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to review [...]

Psychemedics Announces Quarterly Results

23/10/2018 - 23:30

Declares 89 th Consecutive Quarterly Dividend ACTON, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2018 [...]

BioCryst to Report Third Quarter 2018 Financial Results on November 6

23/10/2018 - 22:15

RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will report its third quarter 2018 financial results on Tuesday, November 6, [...]

Cutera, Inc. to Announce Third Quarter 2018 Results

23/10/2018 - 22:05

BRISBANE, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will announce [...]

SeaSpine to Report Third Quarter 2018 Financial Results on November 6, 2018

23/10/2018 - 22:05

CARLSBAD, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018

23/10/2018 - 22:05

SANTA BARBARA, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its third quarter 2018 [...]